Text Size

Prospective Database for Acute Myeloblastic Leukemia

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
King Faisal Specialist Hospital & Research Center
ClinicalTrials.gov Identifier:
NCT00538278
First received: October 1, 2007
Last updated: December 11, 2011
Last verified: December 2011
History of Changes
  Purpose

Prospective Database for Acute Myeloblastic Leukemia


Condition Intervention
Leukemia, Myeloblastic, Acute
 Other: Database

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Health Services Research

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by King Faisal Specialist Hospital & Research Center:

Primary Outcome Measures:
  • safety and efficacy [ Time Frame: 10 years ] [ Designated as safety issue: No ]

Estimated Enrollment: 2000
Study Start Date: October 2007
Estimated Study Completion Date: October 2020
Estimated Primary Completion Date: October 2020 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: Database
    database
    Other Name: Registry
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with AML
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00538278

Sponsors and Collaborators
King Faisal Specialist Hospital & Research Center
Investigators
Principal Investigator: Naeem Chaudhri, MD King Faisal Specialist Hospital & Research Centre
  More Information

No publications provided

Responsible Party: King Faisal Specialist Hospital & Research Center
ClinicalTrials.gov Identifier: NCT00538278     History of Changes
Other Study ID Numbers: RAC #2051-057
Study First Received: October 1, 2007
Last Updated: December 11, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by King Faisal Specialist Hospital & Research Center:
AML

Additional relevant MeSH terms:
Leukemia
Leukemia, Myeloid, Acute
Neoplasms by Histologic Type
Neoplasms
Leukemia, Myeloid

ClinicalTrials.gov processed this record on May 16, 2013